HNGE logo

HNGE

Research Snapshot

Static fundamentals, valuation context, and investor signals for Hinge Health, Inc. (HNGE).

DCF ready

Valuation

N/A

EV/FCF, N/A FCF yield

Quality

-295.7%

ROIC, 29.0% FCF margin

Growth

N/A

5Y sales (revenue) CAGR

Balance sheet

0.0x

Debt/equity, 1.5x current ratio

Superinvestors

1

Top: First Eagle Investment Management (0.0%)

Strengths to research

  • Free cash flow margin is healthy at 29.0%.
  • Debt/equity looks manageable at 0.0x.

Watchouts

  • Valuation multiples are limited or unavailable.
Annual data: 3 periods
Quarterly data: 8 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026

Quality Scorecard

Build-time composite score for HNGE.

Grade F
3
/ 100

Financial Charts

No financial data available for HNGE (annual).

1 superinvestors own HNGE

Current quarter ownership and quarter-over-quarter share changes.

Superinvestor ownership
FundSharesValue% PortfolioQoQ Change
First Eagle Investment Management

First Eagle Investment Management

336,942$13M0.02%0.0%